Rankings
▼
Calendar
NVCR Q1 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena
NVCR
NovoCure Limited
$1B
Q1 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$135M
+32.3% YoY
Gross Profit
$108M
80.4% margin
Operating Income
-$88,000
-0.1% margin
Net Income
-$4M
-3.1% margin
EPS (Diluted)
$-0.04
QoQ Revenue Growth
-6.4%
Cash Flow
Operating Cash Flow
$18M
Free Cash Flow
$14M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$695M
Stockholders' Equity
$372M
Cash & Equivalents
$315M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$135M
$102M
+32.3%
Gross Profit
$108M
$77M
+40.1%
Operating Income
-$88,000
-$3M
+97.4%
Net Income
-$4M
$4M
-204.5%
Geographic Segments
UNITED STATES
$86M
64%
GERMANY
$26M
20%
EMEA, Exculding Germany
$9M
6%
JAPAN
$8M
6%
CHINA
$6M
4%
← FY 2021
All Quarters
Q2 2021 →